Paid Clinical Trials in Oklahoma

Oklahoma has 777 paid clinical trials enrolling now across cities including Oklahoma City, Tulsa and Edmond. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 21, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

710 clinical trials

↓ Download CSV

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

for Thrombotic Thrombocytopenic Purpura

1 location in Oklahoma City

Sponsor: Insel Gruppe AG, University Hospital Bern

Sex: All·Age: All ages

Code: NCT01257269·Recruiting·Listed Dec 2010

Apply to this trial

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

for Acute Ischemic Stroke

Sites in Oklahoma City +50 more locations

Sponsor: Mercy Health Ohio

Sex: All·Age: 18 - 79

Code: NCT05611242·Phase 3·Recruiting·Listed Nov 2022

Apply to this trial

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for Aortic Stenosis

Sites in Oklahoma City +54 more locations

Sponsor: University of British Columbia

Sex: All·Age: All ages

Code: NCT04634240·Recruiting·Listed Nov 2020

Apply to this trial

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

for Peripartum Cardiomyopathy, Postpartum

Sites in Oklahoma City +60 more locations

Sponsor: Dennis M. McNamara, MD, MS

Sex: Female·Age: 18+

Code: NCT05180773·Phase 4·Recruiting·Listed Jan 2022

Apply to this trial

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

for Neuromyelitis Optica

Sites in Oklahoma City +9 more locations

Sponsor: Ad scientiam

Sex: All·Age: 18+

Code: NCT05566769·Recruiting·Listed Oct 2022

Apply to this trial

Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome (AAC-BeT)

for Anxiety

1 location in Tulsa

Sponsor: Laureate Institute for Brain Research, Inc.

Sex: All·Age: 18 - 65

Code: NCT04426461·Recruiting·Listed Jun 2020

Apply to this trial

Neuromodulation of Inflammation and Endothelial Function

for Systolic Heart Failure

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18 - 85

Code: NCT05230732·Recruiting·Listed Feb 2022

Apply to this trial

Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma

for Asthma

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18 - 99

Code: NCT02241265·Recruiting·Listed Sep 2014

Apply to this trial

Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

for Asthma in Children

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 5 - 17

Code: NCT06137040·EARLY_Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

tDCS for Post-Stroke Cognitive Impairment

for Stroke

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: 18 - 99

Code: NCT06516588·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Substance Use Treatment and Access to Resources (STARS) Project

for Substance Use Disorders

1 location in Oklahoma City

Sponsor: University of Oklahoma

Sex: All·Age: Up to 55

Code: NCT04459000·Recruiting·Listed Jul 2020

Apply to this trial

Artificial Intelligence to Measure Adherence to Oral Medication

for First Episode Psychosis

Sites in Oklahoma City, Tulsa +3 more locations

Sponsor: Northwell Health

Sex: All·Age: 15 - 40

Code: NCT04046497·Phase 4·Recruiting·Listed Aug 2019

Apply to this trial

Behavioral Activation + Occupational Therapy: An Innovative Intervention for Empowered Self-Management of Multiple Chronic Conditions

for Multiple Chronic Conditions

1 location in Tulsa

Sponsor: University of Oklahoma

Sex: All·Age: 60+

Code: NCT05600465·Recruiting·Listed Oct 2022

Apply to this trial

Dismantling Exposure, Relaxation, and Rescripting Therapy

for Frequent Trauma-related Nightmares

1 location in Tulsa

Sponsor: University of Tulsa

Sex: All·Age: 18+

Code: NCT02236377·Recruiting·Listed Sep 2014

Apply to this trial

Endothelial Derived Hyperpolarization Factor and Vascular Control

for Healthy

1 location in Norman

Sponsor: University of Oklahoma

Sex: All·Age: 18 - 30·Accepts healthy volunteers

Code: NCT05176379·Phase 4·Recruiting·Listed Jan 2022

Apply to this trial

Liver Cancer Disparities in American Indian and Alaska Native Persons

for Hepatocellular Carcinoma

1 location in Tahlequah

Sponsor: University of Washington

Sex: All·Age: 18 - 75

Code: NCT05304234·Phase 2·Recruiting·Listed Mar 2022

Apply to this trial

The Oklahoma Parent-Child Assistance Program

for Substance Use Disorders

Sites in Oklahoma City & Tulsa

Sponsor: University of Oklahoma

Sex: Female·Age: 18+

Code: NCT05534568·Recruiting·Listed Sep 2022

Apply to this trial

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Oklahoma City +3 more locations

Sponsor: Brian Jonas

Sex: All·Age: 18+

Code: NCT04905810·Phase 2·Recruiting·Listed May 2021

Apply to this trial

Gastrointestinal Interoception in Anorexia Nervosa

for Anorexia Nervosa

1 location in Tulsa

Sponsor: Laureate Institute for Brain Research, Inc.

Sex: Female·Age: 15 - 40·Accepts healthy volunteers

Code: NCT05111977·Recruiting·Listed Nov 2021

Apply to this trial

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

for Liver Fibrosis

Sites in Yukon +19 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07610837·Phase 2·Recruiting·Listed May 28, 2026

Apply to this trial

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for Irritable Bowel Syndrome

Sites in Tulsa, Norman +108 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 80

Code: NCT07519395·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

for Asthma

Sites in Oklahoma City +10 more locations

Sponsor: AstraZeneca

Sex: All·Age: 4 - 11

Code: NCT07525375·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

for Asthma

Drug: Depemokimab

Sites in Oklahoma City +7 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 12+

Code: NCT07456033·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

for Systemic Lupus Erythematosus

Sites in Oklahoma City +26 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 70

Code: NCT07430306·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

for Eosinophilic Asthma

Sites in Edmond +26 more locations

Sponsor: Kymera Therapeutics, Inc.

Sex: All·Age: 18 - 75

Code: NCT07323654·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for Fibromyalgia

Sites in Tulsa +15 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07398417·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

for Turner Syndrome

Sites in Oklahoma City +16 more locations

Sponsor: Ascendis Pharma A/S

Sex: All·Age: 2 - 17

Code: NCT07221851·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for Chronic Obstructive Pulmonary Disease (COPD)

Drug: AZD6793

Sites in Oklahoma City, Tulsa +74 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40+

Code: NCT07082738·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for Chronic Inflammatory Demyelinating Polyneuropathy

Sites in Yukon +31 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18+

Code: NCT07032662·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for Graves' Disease

Drug: IMVT-1402

Sites in Oklahoma City +32 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 75

Code: NCT07018323·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Drug: AZD0780

Sites in Oklahoma City, Norman +294 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for Generalized Myasthenia Gravis

Drug: IMVT-1402

Sites in Oklahoma City, Yukon +45 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 80

Code: NCT07039916·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for Growth Hormone Deficiency (GHD)

Sites in Oklahoma City +27 more locations

Sponsor: Lumos Pharma

Sex: All·Age: 3 - 11

Code: NCT06948214·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for Endometrial Cancer

Drug: Rilvegostomig

Sites in Oklahoma City +44 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06989112·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for Hepatocellular Carcinoma

Drug: Rilvegostomig

Sites in Oklahoma City +30 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06921785·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Oklahoma City, Tulsa +347 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

for Asthma

Sites in Oklahoma City +17 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 12 - 17

Code: NCT05757102·Phase 3·Recruiting·Listed Mar 2023

Apply to this trial

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for Asthma

Sites in Oklahoma City, Yukon +88 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12 - 17

Code: NCT06307665·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

for Atopic Dermatitis

Sites in Tulsa +13 more locations

Sponsor: LEO Pharma

Sex: All·Age: 6 Months - 11

Code: NCT06311682·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

for Chronic Obstructive Pulmonary Disease (COPD)

Sites in Oklahoma City +62 more locations

Sponsor: AstraZeneca

Sex: All·Age: 40 - 80

Code: NCT06883305·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial